Treatment of nodular prurigo with cyclosporin in microemulsion

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Nodular prurigo is a chronic dermatitis characterized by very intense pruritus. The treatment is often unsatisfactory. METHODS: Two patients, suffering from chronic, widespread and therapy-resistant nodular prurigo, were treated with cyclosporin in microemulsion. The drug was used orally, at dosage of 3 mg/kg per day for 2 months, followed by 2.5 mg/kg per day for 2 months and by 2 mg/kg per day for 2 months. During the therapy no other topical or systemic drugs were used. RESULTS: In both patients pruritus regressed almost completely within 2 weeks, whereas the morphology of the lesions changed slightly (minimal reduction in infiltration and erythema). The regression of pruritus was followed by a noteworthy improvement in the quality of life. During follow-up, no relapses of pruritus were reported. CONCLUSION: On the basis of this experience, cyclosporin in microemulsion can be successfully used in the treatment of chronic, widespread and therapy-resistant nodular prurigo.

Original languageEnglish
Pages (from-to)237-239
Number of pages3
JournalJournal of Dermatological Treatment
Volume10
Issue number4
Publication statusPublished - Dec 1999

Fingerprint

Prurigo
Cyclosporine
Pruritus
Therapeutics
Dermatitis
Erythema
Pharmaceutical Preparations
Quality of Life
Recurrence

Keywords

  • Cyclosporin
  • Cyclosporin in microemulsion
  • Nodular prurigo

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of nodular prurigo with cyclosporin in microemulsion. / Veraldi, S.

In: Journal of Dermatological Treatment, Vol. 10, No. 4, 12.1999, p. 237-239.

Research output: Contribution to journalArticle

@article{a77451c63bec481a8c92af0f3d5edc40,
title = "Treatment of nodular prurigo with cyclosporin in microemulsion",
abstract = "BACKGROUND: Nodular prurigo is a chronic dermatitis characterized by very intense pruritus. The treatment is often unsatisfactory. METHODS: Two patients, suffering from chronic, widespread and therapy-resistant nodular prurigo, were treated with cyclosporin in microemulsion. The drug was used orally, at dosage of 3 mg/kg per day for 2 months, followed by 2.5 mg/kg per day for 2 months and by 2 mg/kg per day for 2 months. During the therapy no other topical or systemic drugs were used. RESULTS: In both patients pruritus regressed almost completely within 2 weeks, whereas the morphology of the lesions changed slightly (minimal reduction in infiltration and erythema). The regression of pruritus was followed by a noteworthy improvement in the quality of life. During follow-up, no relapses of pruritus were reported. CONCLUSION: On the basis of this experience, cyclosporin in microemulsion can be successfully used in the treatment of chronic, widespread and therapy-resistant nodular prurigo.",
keywords = "Cyclosporin, Cyclosporin in microemulsion, Nodular prurigo",
author = "S. Veraldi",
year = "1999",
month = "12",
language = "English",
volume = "10",
pages = "237--239",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Treatment of nodular prurigo with cyclosporin in microemulsion

AU - Veraldi, S.

PY - 1999/12

Y1 - 1999/12

N2 - BACKGROUND: Nodular prurigo is a chronic dermatitis characterized by very intense pruritus. The treatment is often unsatisfactory. METHODS: Two patients, suffering from chronic, widespread and therapy-resistant nodular prurigo, were treated with cyclosporin in microemulsion. The drug was used orally, at dosage of 3 mg/kg per day for 2 months, followed by 2.5 mg/kg per day for 2 months and by 2 mg/kg per day for 2 months. During the therapy no other topical or systemic drugs were used. RESULTS: In both patients pruritus regressed almost completely within 2 weeks, whereas the morphology of the lesions changed slightly (minimal reduction in infiltration and erythema). The regression of pruritus was followed by a noteworthy improvement in the quality of life. During follow-up, no relapses of pruritus were reported. CONCLUSION: On the basis of this experience, cyclosporin in microemulsion can be successfully used in the treatment of chronic, widespread and therapy-resistant nodular prurigo.

AB - BACKGROUND: Nodular prurigo is a chronic dermatitis characterized by very intense pruritus. The treatment is often unsatisfactory. METHODS: Two patients, suffering from chronic, widespread and therapy-resistant nodular prurigo, were treated with cyclosporin in microemulsion. The drug was used orally, at dosage of 3 mg/kg per day for 2 months, followed by 2.5 mg/kg per day for 2 months and by 2 mg/kg per day for 2 months. During the therapy no other topical or systemic drugs were used. RESULTS: In both patients pruritus regressed almost completely within 2 weeks, whereas the morphology of the lesions changed slightly (minimal reduction in infiltration and erythema). The regression of pruritus was followed by a noteworthy improvement in the quality of life. During follow-up, no relapses of pruritus were reported. CONCLUSION: On the basis of this experience, cyclosporin in microemulsion can be successfully used in the treatment of chronic, widespread and therapy-resistant nodular prurigo.

KW - Cyclosporin

KW - Cyclosporin in microemulsion

KW - Nodular prurigo

UR - http://www.scopus.com/inward/record.url?scp=0033374418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033374418&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033374418

VL - 10

SP - 237

EP - 239

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 4

ER -